UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant
Filed by a Party other than the Registrant
Check the appropriate box:
Preliminary Proxy Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
xDefinitive Additional Materials
Soliciting Material Pursuant to §240.14a-12
Serina Therapeutics, Inc.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):
No fee required.
Fee paid previously with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.




serinatherapeuticsinc_vxnac.jpg



serinatherapeuticsinc_vxnab.jpg


Serina Therapeutics (AMEX:SER)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Serina Therapeutics Charts.
Serina Therapeutics (AMEX:SER)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Serina Therapeutics Charts.